CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 127 enrolled
Drug / intervention
Contingency Managementbehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03224546
NCT03224546N/ACompleted

Cardiovascular, Immune and Psychosocial Benefits of Reduced Cocaine Use

William Stoops·interventional·Posted Jul 21, 2017·Updated Aug 1, 2024

In Brief

A clinical study evaluating Contingency Management for Cocaine Use Disorder. Completed, enrolled 127 participants across 1 site.

Detailed Summary

Reduced drug use is a clinically meaningful target for treatment development, but few studies have evaluated the positive impacts produced by this behavioral change, preventing adoption of this endpoint in clinical trials. The proposed research will fill that critical knowledge gap by demonstrating the biopsychosocial benefits of reduced cocaine use. These data will be used to change current accepted cocaine treatment endpoints and accelerate identification of therapies for cocaine use disorder.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
201820192020202120222023202420252026
First PostedJul 21, 2017
Enrollment StartSep 15, 2017
Primary CompletionJan 15, 2024
TodayJul 2, 2026
Enrollment to primary: 6.3 yearsPosted 8.9 years ago

Interventions

Contingency Managementbehavioral

Subjects will receive payments for providing cocaine negative urine samples.